|
Mark Leschly serves as a director of the company. Since July 1999, Mr. Leschly has been a managing partner with Rho Capital Partners, Inc., an investment and venture capital management company. From 1994 to July 1999, Mr. Leschly was an associate and then a general partner of Healthcare Ventures L.L.C., a venture capital management company. From 1991 to 1993, Mr. Leschly served as a consultant for McKinsey & Co., a management consulting company. Mr. Leschly is currently a director of Diversa Corporation, a genomic technology company, and NitroMed, Inc., a genomic technology company. He received his B.A. degree in history from Harvard University and his M.B.A. from the Stanford Graduate School of Business. | 